Literature DB >> 21659434

Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.

David M Mannino1, Enrique Diaz-Guzman2.   

Abstract

BACKGROUND: The GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages for COPD use a fixed ratio of the postbronchodilator FEV(1)/FVC ratio of 0.70 as a threshold to define obstruction. Others advocate using the lower limit of normal (LLN) for the FEV(1)/FVC ratio, FEV(1), and FVC to define abnormality. This study investigated mortality in a representative sample of the US adult population with COPD by comparing abnormality determined using GOLD criteria to that determined using LLN criteria.
METHODS: We used baseline data from the Third National Health and Nutrition Examination Survey and follow-up mortality data. We classified subjects as obstructed, restricted, or normal based on GOLD vs LLN criteria and used Cox proportional hazards models to determine the relation between lung function impairment and mortality, adjusting for covariates.
RESULTS: The study sample included 13,847 subjects, of whom 3,774 died during the follow-up period. Of subjects classified as obstructed and restricted using GOLD criteria, 20.9% and 18.0%, respectively, were classified as normal using LLN criteria. Compared with people with normal lung function, mortality was increased in the obstructed (hazard ratio, 1.46; 95% CI, 1.21-1.86) and restricted (hazard ratio, 1.94; 95% CI, 1.58-2.39) subjects classified as normal using the LLN.
CONCLUSIONS: In the nationally representative Third National Health and Nutrition Examination Survey data, subjects classified as normal using LLN criteria but obstructed or restricted using GOLD criteria have a higher risk of mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21659434     DOI: 10.1378/chest.11-0797

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.

Authors:  Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Patricia A Cassano; David Couper; David R Jacobs; Ravi Kalhan; George T O'Connor; Sachin Yende; Jason L Sanders; Jason G Umans; Mark T Dransfield; Paulo H Chaves; Wendy B White; Elizabeth C Oelsner
Journal:  JAMA       Date:  2019-06-25       Impact factor: 56.272

2.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

Review 3.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

4.  Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic.

Authors:  Chantal Robitaille; Esther Dajczman; Andrew M Hirsch; David Small; Pierre Ernst; Dana Porubska; Mark Palayew
Journal:  Can Respir J       Date:  2015-05-11       Impact factor: 2.409

5.  Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study.

Authors:  Elizabeth C Oelsner; Eric A Hoffman; Aaron R Folsom; J Jeffrey Carr; Paul L Enright; Steven M Kawut; Richard Kronmal; David Lederer; Joao A C Lima; Gina S Lovasi; Steven Shea; R Graham Barr
Journal:  Ann Intern Med       Date:  2014-12-16       Impact factor: 25.391

6.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

7.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

8.  Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.

Authors:  Reinier P Akkermans; Marvin A Berrevoets; Ivo J Smeele; Annelies E Lucas; Bart P Thoonen; Joke G Grootens-Stekelenburg; Yvonne F Heijdra; Chris van Weel; Tjard R Schermer
Journal:  BMC Pulm Med       Date:  2012-03-22       Impact factor: 3.317

9.  COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Authors:  Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

10.  Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.

Authors:  Daniel E Murphy; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.